Tempus AI Stock Surges Amid AI App Launch and Pelosi Investment

What's Going On With Tempus AI Shares Wednesday? - Tempus AI (NASDAQ:TEM)

Several AI-related stocks are rising Wednesday after U.S. President Donald Trump announced a $500 billion AI infrastructure investment. Tempus AI Inc TEM shares are trading higher Wednesday. The stock appears to be moving on continued momentum from Tuesday's session. Here's a look at what you need to know. What To Know: Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed in a new filing that she purchased 50 call options in Tempus AI on Jan. 14. The calls have a strike price of $20 and don't expire until Jan. 16, 2026. Tempus AI also announced the launch of its AI-enabled personal health concierge app Olivia on Tuesday. The app allows patients to track their health-related data in one central location and leverages advanced AI to provide actionable insights. "At Tempus, our goal has always been to improve patient outcomes by harnessing the power of data and AI. Now, as AI becomes increasingly integrated into healthcare, tools like Olivia will be essential in helping patients understand and navigate their care," said Eric Lefkofsky, founder and CEO of Tempus. "This app goes beyond organizing information; it's a proactive partner empowering patients to steer their health with confidence and clarity." Tempus AI is a technology company that aims to advance precision medicine by applying AI to healthcare. It's possible that the stock is getting an additional boost Wednesday from AI optimism after U.S. President Donald Trump announced a $500 billion AI infrastructure investment called Project Stargate. Trump on Tuesday said OpenAI, SoftBank and Oracle are planning a joint venture to build out data centers. Project Stargate and its backers have committed $100 billion for immediate investment, with up to $400 billion in additional investments expected to take place over the next four years. TEM Price Action: Tempus AI shares closed Tuesday up approximately 35%. The stock was up another 4.1% Wednesday morning, trading at $49.68 at the time of publication, according to Benzinga Pro. Read Next: Seagate Ramps Up Technology For AI, Delivers Profitable Growth In Q2 Photo: courtesy of Tempus AI. TEMTempus AI Inc$49.453.80%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

Tempus AI Stock Is Trading Higher Tuesday: What's Going On? - Tempus AI (NASDAQ:TEM)

Tempus AI on Tuesday announced the national launch of its AI-enabled personal health concierge app Olivia. Tempus AI Inc TEM shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position in the technology company. What Happened: Pelosi disclosed in a new filing that she purchased 50 call options in Tempus AI on Jan. 14 with a strike price of $20. The value of the calls is between $50,000 and $100,000, and they are not set to expire until Jan. 16, 2026. Tempus AI is a technology company that aims to advance precision medicine by applying AI to healthcare. The company went public in 2024, but shares have traded lower since its public debut. The stock was up more than 17% at last check on the disclosure from Pelosi. Pelosi also bought call options in Alphabet, Amazon and Nvidia, according to the filing. Tempus AI on Tuesday announced the national launch of its AI-enabled personal health concierge app Olivia. The app is designed to empower patients by bringing their health-related data into one central location and then leveraging advanced AI to provide actionable insights. "At Tempus, our goal has always been to improve patient outcomes by harnessing the power of data and AI. Now, as AI becomes increasingly integrated into healthcare, tools like Olivia will be essential in helping patients understand and navigate their care," said Eric Lefkofsky, Founder and CEO of Tempus. "This app goes beyond organizing information; it's a proactive partner empowering patients to steer their health with confidence and clarity." See Also: US Stocks Set To Open On A Positive Note As Trump's Second White House Term Kicks Off: Tesla, Apple, Netflix Among Stocks In Focus TEM Price Action: Tempus AI shares were up 18.0% at $41.48 at the time of publication Tuesday, according to Benzinga Pro. Photo: Pixabay. TEMTempus AI Inc$41.3417.6%WatchlistOverviewMarket News and Data brought to you by Benzinga APIs

Here's Why This Medical AI Stock Soared 35% on Tuesday

Some analysts expect software companies like Tempus to be major beneficiaries of AI this year as they roll out AI agents -- digital assistants with greater autonomy than chatbots. Tempus AI (TEM) stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge and former House Speaker Nancy Pelosi revealed she's bet on the stock. Tempus on Tuesday morning launched olivia, "an AI-enabled personal health concierge app designed to empower patients by bringing their health-related data into one central location and leveraging advanced AI to provide actionable insights." The app, according to a press release, can integrate with Apple Watch and Google Fit to track a user's day-to-day health, summarize their clinical history, and transcribe doctors' appointments. Tempus CEO Eric Lefkofsky emphasized olivia "goes beyond organizing information; it's a proactive partner" of patients navigating their health and care. Tempus shares jumped 35.5% on Tuesday, the biggest one-day jump since the stock debuted in June. The market's reaction to olivia could reflect a changing AI narrative on Wall Street. Since 2022, the Magnificent Seven and other companies vital to the buildout of AI infrastructure have been the main beneficiaries of the AI craze. In November, Goldman Sachs analysts predicted the AI revolution would enter "Phase 3" this year, during which a wider variety of companies will see artificial intelligence meaningfully contribute to their top and bottom lines. They expect software companies in particular to benefit as they launch AI agents like olivia -- digital assistants capable of greater autonomy than chatbots like ChatGPT. Tempus stock also got a boost from a routine stock trading disclosure from former House Speaker Nancy Pelosi, who on January 14 purchased 50 call options expiring in January 2026 with a strike price of $20. Tempus stock closed just under $32 on the day of Pelosi's trade, and on Tuesday closed at $47.64. Pelosi, whose husband owns a venture capital firm, is one of Washington's most prolific traders. An ETF tracking the investments of Congressional Democrats launched in 2023 with the ticker "NANC," a nod to Pelosi's reputation.

Why Tempus Ai Stock Is Skyrocketing Today | The Motley Fool

Tempus Ai (TEM 35.53%) stock is seeing an explosive valuation surge in Tuesday's trading thanks to a pair of catalysts. The healthcare software company's share price was up 35.8% as of 3:15 p.m. ET, and had been up as much as 41.8% earlier in the day. In a recently published disclosure filing, Congresswoman Nancy Pelosi showed that she had purchased call options for Tempus Ai stock. The healthcare artificial intelligence (AI) company's share price is also getting a boost from a press release announcing the company's new software platform. As a member of Congress, Nancy Pelosi is required to submit filings that disclose her and her husband's stock sales and purchases. Along those lines, the former House speaker's most recent disclosure showed that she had purchased 50 call options for Tempus Ai stock. These options had a strike price of $20 per share, and the overall trade had a value between $50,000 and $100,000. Pelosi makes frequent stock market moves and has generally recorded very strong performance with her trades. According to an analysis conducted by UnusualWhales, Pelosi recorded gains of 70.9% on her stock trades in 2024 -- far exceeding the roughly 25% gain for the S&P 500 (^GSPC 0.88%) across the stretch. In response to market-beating performance for her trades, some investors have been paying close attention to Pelosi's market moves and replicating her purchases and sales. In addition to gains powered by Pelosi's options purchase disclosure, Tempus Ai stock is also getting a boost from the rollout of its AI-powered olivia healthcare app. The software is designed to combine and organize a patient's health data in a single source and use that information to generate care insights. Tempus says that the software allows patients to connect electronic health record (EHR) data from over 1,000 healthcare systems and digital health devices. The app can then provide patients with timelines, summaries, and insights that can be used by healthcare teams. Despite today's explosive gains, Tempus Ai is up just 16% over the last year of trading, as of this writing. It's also still down roughly 40% from the high it reached in November. The software specialist has a relatively short history as a publicly traded company, having just gone public this past June. With the preliminary full-year results it published earlier this month, Tempus announced that it anticipates revenue to have grown 30% annually to reach $693 million in 2024. The rollout of its new software platform could help growth keep coming in strong in 2025.

Tempus AI shares set to rally as Pelosi buys calls By Investing.com

Investing.com-- Shares of Tempus AI Inc (NASDAQ:TEM) are set to rally on Tuesday after former House Speaker Nancy Pelosi disclosed that she had purchased call options on the stock. Tempus' shares jumped over 18% to $41.62 in 24 hour markets, data from Robinhood (NASDAQ:HOOD) showed. Pelosi disclosed in a filing that she had purchased 50 call options in the AI firm with a strike price of $20 and an expiration date of Jan 16, 2026, for between $50,000 to $100,000 earlier this month. Pelosi had also disclosed call options in Alphabet Inc (NASDAQ:GOOGL), NVIDIA Corporation (NASDAQ:NVDA), and Amazon.com Inc (NASDAQ:AMZN). Tempus- which uses artificial intelligence technology in precision medicine applications, publicly listed in June 2024, and is trading down about 12% since listing. Recent filings showed a major shareholder in the firm had sold about $33.1 million worth of shares last week, after the company clocked strong 2024 earnings but flagged some weakness in its contract research organization revenues. Trading social media platform Stocktwits showed sentiment on Tempus was extremely bullish, and that discussion over the stock had also increased sharply after Pelosi's disclosure.